VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
11 hedge funds and large institutions have $22.1M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
12% more capital invested
Capital invested by funds: $19.7M → $22.1M (+$2.39M)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$7.76M |
| 2 |
TFCP
Twin Focus Capital Partners
Boston,
Massachusetts
|
+$49.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$199K |
| 2 |
Goldman Sachs
New York
|
-$81K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$48K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$535 |
VBIV Hedge Fund Activity: Q1 2015 in Review
11 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2015, worth a combined $22.1M — up 12% from $19.7M a quarter earlier.
Fund positioning in VBIV was balanced in Q1 2015: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $7.76M. The largest seller was Hudson Bay Capital Management, cutting an estimated $199K.
- 11 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $22.1M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2015, up 12% quarter-over-quarter.
- 2 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2015 and 2 closed out, a net change of 0 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2015 was Perceptive Advisors, an estimated $7.76M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2015 was Hudson Bay Capital Management, an estimated $199K sold.
Based on aggregated 13F filings for Q1 2015.